幽门螺杆菌
胃活检
抗生素
胃肠病学
抗生素耐药性
内科学
医学
螺杆菌感染
生物
微生物学
胃炎
作者
Steven F. Moss,Long P. Dang,David Chua,Javier Sobrado,Yi Zhou,David Y. Graham
出处
期刊:Gastroenterology
[Elsevier BV]
日期:2022-02-20
卷期号:162 (7): 2095-2097.e2
被引量:41
标识
DOI:10.1053/j.gastro.2022.02.027
摘要
Helicobacter pylori cure rates have declined worldwide, making pretreatment susceptibility testing increasingly important.1–3 Many US diagnostic laboratories now offer culture and susceptibility testing. In addition, molecular-based testing using next-generation sequencing (NGS) is now available in the United States.4 NGS provides susceptibility profiling based on detection of mutations in the H pylori genome associated with phenotypic resistance.5 Advantages of NGS include detecting resistance to multiple antibiotics simultaneously and rapidly4 and providing results comparable with culture-based methods using either fresh or formalin-fixed gastric biopsies.
科研通智能强力驱动
Strongly Powered by AbleSci AI